A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Public ClinicalTrials.gov record NCT02549170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Study identification
- NCT ID
- NCT02549170
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Baxalta now part of Shire
- Industry
- Enrollment
- 138 participants
Conditions and interventions
Interventions
- HYQVIA Biological
- 0.25% albumin placebo solution with rHuPH20 Biological
- IGIV GAMMAGARD LIQUID/KIOVIG Biological
- IGIV GAMUNEX®-C Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 14, 2015
- Primary completion
- Feb 22, 2022
- Completion
- Feb 22, 2022
- Last update posted
- May 23, 2023
2015 – 2022
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | 85013 | — |
| Arizona Neuromuscular Research Center | Phoenix | Arizona | 85028 | — |
| HonorHealth Neurology | Scottsdale | Arizona | 85251 | — |
| University of California-Irvine | Orange | California | 92868 | — |
| Forbes Norris Mda/als Ctr | San Francisco | California | 94109 | — |
| Regents of the University of colorado | Aurora | Colorado | 80045 | — |
| Immunoe Research Centers | Centennial | Colorado | 80112 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| University of Kansas Medical Center Research Institute, Inc. | Kansas City | Kansas | 66160 | — |
| William Beaumont Hospital | Royal Oak | Michigan | 48073-6769 | — |
| Neurology Center of Las Vegas | Las Vegas | Nevada | 89128 | — |
| Rutgers New Jersey Medical School | Newark | New Jersey | 07103 | — |
| Hospital for Special Surgery | New York | New York | 10032 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267-0525 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Austin Neuromuscular Center | Austin | Texas | 78756 | — |
| The Methodist Hospital Research Institute | Houston | Texas | 77030 | — |
| University Texas Physicians CAR | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02549170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 23, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02549170 live on ClinicalTrials.gov.